Methocarbamol Milpharm

Methocarbamol, the active ingredient in Methocarbamol Milpharm, is a centrally acting skeletal muscle relaxant presented as an oral dosage form for oral use. It is used to relieve muscle spasm and associated pain in adult patients. GNH USA supplies Methocarbamol Milpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methocarbamol is a centrally acting muscle relaxant indicated for conditions involving skeletal muscle spasm and pain. - Muscle spasm: reduces involuntary muscle contraction and associated discomfort. - Acute musculoskeletal pain: alleviates pain arising from strains, sprains or injuries. - Skeletal muscle conditions: improves mobility and function in disorders characterized by muscle tightness.

Methocarbamol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Dizziness - Drowsiness - Headache - Nausea - Blurred vision - Gastrointestinal upset

Serious or Rare Side Effects: - Allergic reactions such as rash or angioedema - Severe hypotension - Hepatic enzyme elevation - Blood dyscrasias (e.g., leukopenia) - Seizures (rare) - Stevens‑Johnson syndrome or toxic epidermal necrolysis

Before initiating therapy, clinicians should consider several safety measures. - Renal or hepatic impairment: assess function and adjust use if needed. - CNS depression: monitor for excessive sedation, especially when combined with other depressants. - Operating machinery: advise patients to avoid driving or hazardous tasks until they know how the drug affects them. - Elderly patients: start at lower doses and watch for increased sensitivity. - Concomitant CNS depressants: review all sedating medications. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Methocarbamol can interact with other medicines that affect the central nervous system or hemostasis.

Major Interactions (Avoid): - Opioid analgesics: additive CNS depression. - Benzodiazepines: increased sedation and respiratory depression. - Alcohol: potentiates drowsiness and dizziness.

Moderate Interactions (Monitor Closely): - Warfarin or other anticoagulants: possible alteration of INR. - Insulin or oral hypoglycemics: may mask hypoglycemia symptoms. - Antihypertensive agents: potential for additive blood pressure lowering.